Breaking news in spinal cord injury research: FDA approved phase I clinical trial of human, autologous schwann cell transplantation in patients with spinal cord injuries

Simple item page
dc.contributor.authorXu, Xiao-Ming
dc.contributor.departmentDepartment of Neurological Surgery, IU School of Medicineen_US
dc.date.accessioned2016-06-27T18:22:38Z
dc.date.available2016-06-27T18:22:38Z
dc.date.issued2012-08-05
dc.identifier.citationXu, X.-M. (2012). Breaking News in Spinal Cord Injury Research: FDA Approved Phase I Clinical Trial of Human, Autologous Schwann Cell Transplantation in Patients with Spinal Cord Injuries. Neural Regeneration Research, 7(22), 1685–1687. http://doi.org/10.3969/j.issn.1673-5374.2012.22.001en_US
dc.identifier.urihttps://hdl.handle.net/1805/10187
dc.language.isoen_USen_US
dc.publisherWanfang Med Onlineen_US
dc.relation.isversionof10.3969/j.issn.1673-5374.2012.22.001en_US
dc.relation.journalNeural Regeneration Researchen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/
dc.sourcePMCen_US
dc.subjectSpinal cord injuryen_US
dc.subjectSchwann cellsen_US
dc.titleBreaking news in spinal cord injury research: FDA approved phase I clinical trial of human, autologous schwann cell transplantation in patients with spinal cord injuriesen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Breaking News in Spinal Cord Injury Research.pdf
Size:
26.45 KB
Format:
Adobe Portable Document Format
Description:
Main Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.88 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Policy Articles
Department of Neurological Surgery Works